HHS Stock Alert: Halper Sadeh LLC is Investigating Whether Harte Hanks, Inc. is Obtaining a Fair Price for its Shareholders

Halper Sadeh LLC is investigating Harte Hanks’ proposed sale to Star Equity Holdings. Under the transaction terms, Harte Hanks shareholders may elect $5.00 cash per share or 0.50 shares of Star Equity’s publicly traded 10% Series A Cumulative Perpetual Preferred Stock for each Harte Hanks share.

Analysis

The central valuation question is not the headline coupon but the cash-equivalent value and certainty of the preferred-stock election. A 10% cumulative perpetual preferred can carry substantial duration and issuer-credit risk; its market value depends on the actual dividend base, redemption and liquidation terms, payment mechanics, and liquidity—none of which are established here. For Harte Hanks (HHS), the $5 cash election is a reference ceiling only if the deal closes on schedule and shareholders can actually elect cash without material proration or other constraints. The preferred alternative may be worth less than its stated coupon suggests, particularly if Star Equity Holdings (STRR) credit spreads widen or rates rise.

The law-firm investigation is not evidence of misconduct or a likely injunction. Near term, it may add noise to HHS’s deal spread; a credible claim, court action, or delay would matter more than the announcement itself. Over 1–3 months, focus on definitive deal terms, shareholder-election mechanics, approvals, and closing conditions. Over 6–18 months, any preferred issuance could increase STRR’s fixed or cumulative distribution burden and refinancing sensitivity, even though preferred shares are not common-equity dilution.

Contrarian angle: investors may anchor on “10%” and underweight perpetual duration and STRR credit risk. Conversely, treating a routine investigation notice as a deal break is likely an overreaction absent substantive legal developments. No standalone trade is warranted without HHS’s market price, the preferred’s current quote and terms, and election/proration details.

Key Decisions for Investors

• Track HHS against the cash consideration and calculate the deal spread only after confirming the current price, expected closing date, termination rights, and probability of proration. A spread that fails to compensate for delay and break risk is not attractive merely because cash consideration is stated.
• Do not value the preferred election from its coupon alone. Verify the dividend base, liquidation preference, call/redemption provisions, cumulative-dividend treatment, trading liquidity, and election allocation before comparing 0.50 preferred shares with cash.
• Treat the law-firm notice as a watch item, not a directional short catalyst. Reassess if a complaint seeks an injunction, a court grants relief, the companies disclose material deal changes, or the closing timeline slips.
• For STRR, monitor the amount and terms of preferred stock actually issued and subsequent dividend coverage or financing disclosures; the thesis that the security creates meaningful balance-sheet pressure is falsified if issuance is limited or terms and cash flows show the burden is immaterial.